Xuelin Huang

Statistics

Publications

199

Citations

16.6K

H-Index

Active since

2002

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

University of California, Irvine

University of Michigan

Xuelin Huang is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and hematologic malignancy therapy.

ORCID

Publications per year

2002–2025

199

Publications

199

An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis.

Xiayu Rao, Xuelin Huang, Zhicheng Zhou et al. · PubMed · 2013 · 1.6K citations · Full text

Life Sciences, Biostatistics, Molecular Biology +14

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

Hagop M. Kantarjian, Yasuhiro Oki, Guillermo Garcia‐Manero et al. · Blood · 2006 · 689 citations · Full text

Medicine, Oncology, Pharmacology +16

Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study

Koichi Takahashi, Feng Wang, Hagop M. Kantarjian et al. · The Lancet Oncology · 2016 · 400 citations

Medicine, Hematology, Oncology +13

DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes

Lanlan Shen, Hagop M. Kantarjian, Yi Guo et al. · Journal of Clinical Oncology · 2009 · 357 citations · Full text

Medicine, Molecular Biology, Molecular Medicine +17

Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

Michael Andreeff, Kevin R. Kelly, Karen Yee et al. · Clinical Cancer Research · 2015 · 353 citations

Medicine, Oncology, Pharmacology +17

1–5 of 199